Antioxidant Response Activating nanoParticles (ARAPas) localize to atherosclerotic plaque and locally activate the Nrf2 pathway
S. L. Maiocchi, A. Cartaya, S. Thai, A. Akerman, E. M. Bahnson
This study develops ARAPas, nanoparticles that target atherosclerotic plaque and activate the Nrf2 pathway, showing anti-inflammatory effects and increased Nrf2 target gene expression in mouse models.
bioRxiv · Sep 16, 2021Bioengineering